Maternal care for (suspected) chromosomal abnormality in fetus, Turner Syndrome
ICD-10 O35.14 is a billable code used to indicate a diagnosis of maternal care for (suspected) chromosomal abnormality in fetus, turner syndrome.
O35.14 is used to indicate maternal care for a suspected chromosomal abnormality in the fetus, specifically Turner Syndrome. Turner Syndrome is a genetic condition that affects females, characterized by the partial or complete absence of one of the two X chromosomes. This condition can lead to various developmental issues, including short stature, delayed puberty, and infertility. During pregnancy, maternal care involves comprehensive prenatal screening and diagnostic testing, such as chorionic villus sampling (CVS) or amniocentesis, to confirm the diagnosis. The management of pregnancies affected by Turner Syndrome requires a multidisciplinary approach, including genetic counseling and close monitoring of fetal development. Maternal care may also involve addressing potential complications, such as congenital heart defects or renal anomalies, which are more prevalent in fetuses with Turner Syndrome. Proper documentation of maternal care, including the results of genetic testing and any referrals to specialists, is crucial for accurate coding and billing.
Documentation must include prenatal screening results, genetic counseling notes, and any referrals made for further evaluation.
Common scenarios include routine prenatal visits where chromosomal abnormalities are discussed, and referrals for genetic testing.
Coders must ensure that all relevant tests and consultations are documented to support the use of O35.14.
Detailed documentation of high-risk factors, ultrasound findings, and any interventions performed during pregnancy.
Complex maternal-fetal scenarios may involve monitoring for associated anomalies and coordinating care with pediatric specialists.
High-risk coding requires thorough documentation of all assessments and interventions related to the suspected chromosomal abnormality.
Used during routine prenatal visits to monitor fetal development and assess for abnormalities.
Documentation must include the indication for the ultrasound and findings related to Turner Syndrome.
Obstetricians should ensure that ultrasound findings are clearly linked to the suspected chromosomal abnormality.
To support the use of O35.14, documentation must include evidence of genetic counseling, results from any prenatal testing, and a clear plan for monitoring and managing the pregnancy. All relevant clinical findings should be documented to justify the diagnosis.
